Conference Coverage (IHV)
Tat Toxoid Immunogenic, Safe In Human Trials
Published in AIDS Weekly, September 13th, 1999
The immunogen is an inactivated form of the HIV Tat protein. It could be both a vaccine and a treatment for AIDS.
"We have carried out three clinical trials in humans," reported A. Gringeri of IRCCS Maggiore Hospital, Milan, Italy, in a presentation to the 1999 Meeting of the Institute of Human Virology, held August 28-September 2 in Baltimore, Maryland.
Tat toxoid is being developed and tested in a collaboration between Robert Gallo and colleagues of the Institute of Human Virology and Daniel Zagury, Gringeri, and colleagues at IRCCS. C. David Pauza...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1999-09-13)
More Articles from AIDS Weekly
- Conference Coverage (HIV Prevention)
Gayle: U.S. Must Address Disproportionate AIDS Burden - Conference Coverage (HIV Prevention)
New HIV Test Strategy IDs Recent Infection - Vector Development
HIV Vectors Can Be Maintained without gag and env - AIDS Therapies
Once-Daily Didanosine May Be Adequate - Therapy (TB)
Mortality Higher in HIV+ Treated with Twice Weekly DOT - Therapy (TB)
Preventive Treatment Has Place in Underdeveloped Areas - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
